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Abstract: Hepatitis B is a severe infection of liver caused by the hepatitis B virus (HBV) lead to progressive liver 
diseases, such as hepatitis, liver cirrhosis and hepatocellular carcinoma (HCC). It can cause acute and chronic 
infections. HBV infection is one of the serious concerns and a constant threat to public health. WHO ranks HBV 
among the top ten killers. It is estimated that more than 350 million hepatitis B carriers are present worldwide. This 
disease is generally transmitted through exposure to infected body fluids. Perinatal or vertical transmission is the 
major route of transmission in endemic areas. The incubation period of HBV varies from 1 to 6 months. Serological 
tests are conducted to detect antigens and antibodies in the serum of patients. ELISA is used to detect HBV antigen 
and antibody and PCR is used to detect HBV-DNA. There is no treatment available for acute infection. Chronic 
cases can be treated with medications. HBV infection is easily preventable with a vaccine. The present study 
focused on the compilation and review of (30) papers on the prevalence of HBV infection by Iraqi researchers in 
different areas of Iraq. 
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1. Introduction 
 
Hepatitis B virus (HBV) belongs to 
Orthohepadnavirus genus a member of the 
Hepadnaviridae family that leads to hepatitis B, liver 
cancer, and liver cirrhosis (Sadik et al, 2014). HBV 
infection is one of the major concerns and a constant 
threat to public health. It is estimated that there are more 
than 350 million hepatitis B carriers in the world (Zhu et 
al., 2014). HBV causes significant morbidity and 
mortality. Approximately 1 million people die from HBV 
every year, this is equal to around 2 HBV related deaths 
each minute. HBV variants may differ in its virulence, 
models of serologic reactivity, pathogenicity, response to 
treatment and global distribution (Al-Suraifi et al., 2016). 
The prevalence of HBV positivity varies from country to 
country, ranging from 0.5% in some developing countries 
to 8% in some Asian countries (Alavian et al., 2012; 
Baiani et al., 2010). Hepatitis B virus (HBV) is one of the 
most common viruses in modern times and ranked among 
the top 10 killers by the WHO (Othman et al., 2013). 
The history of modern research on viral hepatitis 
started in 1963 when Nobel Prize winner American 
physician and geneticist Baruch S. Blumberg (1925–
2011) for the first time publicly reported on the detection 
of a new antigen called Australia antigen (AuAg) 
(Gerlich, 2013). 
Hepatitis B is an enveloped DNA virus consists of a 
circular, partially double-stranded DNA genome of 
3.2 kb in size, which contains four overlapping open 
reading frames (ORFs) that code for surface proteins 
(HBsAg), core proteins (HBcAg/HBeAg), the 
transcriptional transactivator X protein (HBx) and the 
viral polymerase (Zhang et al., 2006). 
 
2. HBV Transmission, Incubation period, 
Pathogenesis 
 
2.1 HBV Transmission 
Perinatal or vertical transmission is the main cause of 
infection in endemic areas. Perinatal infection often 
occurs when the mother is HBeAg-positive and has a 
high amount of serum HBV-DNA. If HBsAg-positive 
mother does not receive perinatal hepatitis B vaccine and 
immunoglobulin prophylaxis, possibility of infection in 
infants born to HBsAg positive and negative mothers is 
70-90% and 10-20%, respectively, 90% of which 
progress to chronic infection. 
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Transmission route of HBV infection by sexual 
contact between adolescents and adults in the countries 
with low and medium prevalence rates of hepatitis B and 
transfer of blood or serum via shared syringe in drug 
abusers has also been reported.  
Other transmission routes include parenterally by 
skin and mucous membrane infections caused by 
contaminated blood or body fluids (blood transfusion, use 
of contaminated syringes, invasive tests or surgery), and 
indirectly through hemodialysis, razors, toothbrushes 
acupuncture therapy, tattooing, and ear piercing (Kwon & 
Lee, 2011). 
 
2.2  Incubation period 
Hepatitis B is a highly resistant virus which can 
withstand high temperature and humidity. HBV can 
survive when stored at –20°C for 15 years, at –80°C for 
24 months, at room temperature for 6 months and at 44°C 
for 7 days (Willis, 2007).  
 
2.3  Pathogenesis 
HBV plays an important role in the development of 
progressive liver diseases, such as hepatitis, liver 
cirrhosis and hepatocellular carcinoma (HCC). HBV and 
HCV or HIV coinfections may increase the risk of HCC. 
Chronic hepatitis appears to be caused by a suboptimal 
cellular immune response which destroys some of the 
infected hepatocytes and does not purge the virus from 
other infected hepatocytes, this allows the persistent virus 
to cause a chronic, indolent necroinflammatory liver 
disease which sets the stage for HCC development. 
However, HBV-related HCC pathogenesis is 
incompletely clarified. Hepatitis B virus X protein (HBx), 
an important transforming inducer, plays a significant 
role in the occurrence, invasion and metastases of HCC 
(Zhang et al., 2006). 
 
3. Diagnosis and Treatment of HBV 
 
3.1  Diagnosis 
HBV infection can be detected 30-60 days after 
exposure. The diagnosis is usually confirmed by blood 
test for acute and chronic HBV infection. The presence of 
HBsAg and IgM antibody to the core antigen, HBcAg in 
the blood are indicators of acute HBV infection. In the 
initial stage of infection, patients are also seropositive for 
HBeAg. HBeAg is usually a marker for high levels of 
virus replication and indicates that the blood and body 
fluids of the infected individual are highly infectious. 
Chronic infection indicates persistence of HBsAg for a 
minimum period of 6 months. Persistence of HBsAg is 
the main risk factor for the development of chronic liver 
disease and hepatocellular carcinoma (Mahoney, 1999). 
Screening of hepatitis B virus (HBV) is done with 
serological testing. ELISA tests were used to detect HBV 
antigen (HBsAg) and HBV antibodies (HBcAb and 
HBsAb) and PCR tests for HBV-DNA in human plasma 
or serum (Kurdi et al., 2014). 
3.2 Treatment 
HBV infection is easily preventable with a vaccine. 
There is no specific treatment for acute infection, 
treatment is supportive. Patients with evidence of 
chronic infection can be treated with antiviral therapies to 
prevent progression of liver fibrosis and development of 
hepatocellular carcinoma. Pegylated interferon alfa-2a, 
Tenofovir and entecavir are the most potent first-line 
treatments to suppress the hepatitis B virus infection 
(Mahoney, 1999).  
    
3. Hepatitis B Virus (HBV) Infection in Iraq 
 
There are several studies reported on the prevalence 
of HBV infection with other diseases in different areas of 
Iraq. The present study focused on the compilation and 
review of (30) papers on the prevalence of HBV infection 
by Iraqi researchers in different areas of Iraq. 
 
Al-Jadiry et al., (2013), studied the prevalence of 
viral hepatitis in cancer diagnosed children, identify 
variables that might cause this incidence and role of HBV 
vaccination in preventing infection. From September 
2007-June 2008, 256 children were studied in the 
Haemato-oncology unit, Children’s Welfare Teaching 
Hospital, Baghdad. At the time of diagnosis, patients 
were screened for HBV and the findings are negative. 
231 patients (90.2%) were revaccinated when admitted to 
the unit. In 70 patients (27.3%) HBV infection was 
observed at reassessment after cancer treatment. A 
variable such as diagnosis of leukaemia significantly 
increased the risk of HBV infection and receives more 
than 3 blood units. The high rate of HBV infection 
observed in this study. 
 
Ismail (2013), determines the prevalence of HBsAg 
and its associated parameters in pregnant women in 
Baghdad Province. Healthy pregnant women and their 
families have been selected as study subjects and who 
had attained prenatal care clinics in Baghdad province 
from 2010-2012. Of these, 234 cases were selected for 
the study. Their age ranged from 16 to 42 years. 
Serological test was done for HBV using the ELISA test. 
Based on different parameters, HBsAg has been positive 
in pregnant women and their children were negative 
constitute the highest percentage 85.4% and the lowest 
was pregnant women living with positive family history 
of HBV were 8.9%. 
 
Hassab et al., (2016), investigate the distribution of 
serological patterns for HBV, which were negative for 
HBsAg. From July 18, 2011, to December 25, 2011, 
10ml of blood samples from 25782 blood donors (25294 
male, 488 female), mean age (20-65) years were collected 
from National blood Transfusion Center donors, 
Baghdad. Excluded 185 HBsAg positive serum donors. 
Finally, 25597 HBsAg negative blood donors were 
included in the study. By Architect system 1000 (3.8%) 
donors were positive for anti-HBc while HBsAg negative 
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was found in 24597 (95.4%). Among 
1000 cases of previous HBV infection, Anti-HBc with 
anti-HBs was observed in 685 (68.5%). Anti-HBc alone 
was seen in 315 (31.5%) cases. 
 
Thabit et al., (2017), shows awareness of hepatitis B 
infection among Health and Medical Specialty students. 
A cross-sectional analysis, including 107 students was 
carried out at Nursing College and Technical College of 
Health and Medicine, Baghdad during November and 
December 2015. They completed a self-structured 
questionnaire consisted of socio-demographic 
characteristics, source of HBV information and various 
statements regarding HBV knowledge. Academic lectures 
(55.1%) are the main source of HBV information 
followed by mass media 39.2%. The student’s knowledge 
responses were generally disappointing with regard to the 
mode of transmission. 43% of students were correct on 
mother to fetus transmission, 39.2% for sexual 
transmission. 47.6% of students know HBV can be 
transmitted sexually and 39.5% know HBV can be 
perinatal, 62.8% know that HBV can be transmitted by 
using the same toothbrush. Only 41.1% answered 
correctly regarding the risk for physicians and dentists. 
The knowledge responses regarding disease 
Epidemiology and prevention and treatment (vaccination) 
were satisfactory. 
 
Khudair et al., (2019), detect TTV Ag in healthy 
blood donors and patients infected with chronic hepatitis 
B virus or chronic hepatitis C virus by ELISA technique 
and any possible correlation between the study 
population demographic data and TTV status. This study 
was carried out from November 2017 to March 2018. 
Serum samples of 50 patients were collected who had 
chronic hepatitis HBV or HCV from Gastroenterology 
and Hepatology Teaching Hospital. Also, sera were 
collected from 43 healthy blood donors. The clinical 
characteristics of both patients and controls such as 
alanine transaminase (ALT), aspartate transaminase 
(AST), hepatitis C virus antibody (HCV-Ab), hepatitis B 
surface antigen (HBsAg) and hepatitis B core antibody 
(HBcAb) were obtained from hospital records. Serum 
samples were tested by the ELISA technique for 
detection of TTV Ag. TTV was detected in 89.2% 
(33/37) of the HBV-positive patients and in 30.8% (4/13) 
of the HCV-positive patients versus 23.3% of the healthy 
blood donor (10/43). This study showed a significantly 
higher prevalence of TTV in HBV patients than HCV 
patients and healthy blood donors and TTV may play a 
role in hepatitis and has been associated with biochemical 
signs of liver disease and chronic HBV or HCV 
infections. 
 
Hussein et al., (2017), determine the prevalence of 
hepatitis B virus and hepatitis C virus in blood donors in 
Duhok, Northern Iraq. A cross-sectional study was 
carried out on blood donors attending Duhok blood bank. 
In this study, 7900 subjects were included from January 
to December 2014. Subjects were screened for HBsAg 
and HCV-Ab. A questionnaire was collected on 
demographic and personal data of every positive subject. 
All HCV-positive samples were assessed by RT-PCR to 
confirm the results. Among the analyzed sample, the 
prevalence of HBsAg and HCV-Ab were 62/7900 
(0.78%) and 16/7900 (0.2%), respectively. The RT-PCR 
results for quantitation of HCV showed that only 1/7900 
(0.013%) patients were HCV-positive. There was no 
significant difference was observed in the positivity of 
HBV and HCV between urban and rural donors (P> 
0.05). In addition, 77% and 75% of HBV- and HCV-
positive donors, respectively, had a history of dental 
treatment.  
 
Hussein (2018), describes the prevalence and risk 
factors of HBV infection. Blood samples of 438 blood 
donors were collected from blood bank in Duhok city. 
Serum samples were tested by ELISA for HBcAb and 
HBsAg. Different risk factors were noted and 
multivariate analysis was carried out. Of the subjects, 
5/438 (1.14%) were HBsAg positive (HBsAg and HBcAb 
positive) and 36/438 (8.2%) were HBcAb positive. The 
data analysis was therefore focused on 41 cases that have 
been exposed to HBV. Univariate analysis showed that 
there are significant associations between a history of 
illegitimate sexual contact, history of alcohol, or history 
of dental surgeries and HBV exposure (p<0.05 for all). 
Multivariate analysis was then conducted to determine 
HBV exposure predictive factors. The history of dental 
surgery was found to be a predictive factor for virus 
exposure (P=0.03, OR: 2.397) in Duhok city.  
 
Abdulla and Goreal (2016), were conducted a study 
to identify HBV genotypes in chronic HBV carriers 
associated with HBV serological markers. This work was 
carried out in Duhok, Iraq from March to December 2012 
and included 134 HBsAg positive carrier cases. HBV 
genotypes have been detected using specific primers PCR 
techniques. The carrier cases were screened for markers 
of HBV infection by ELISA. The carrier cases were 91 
males (67.9%), 43 females (32.1%), and the age range 
was 10-87 years old (mean=31.4 SD± 13.3). Genotypes 
D was found in 133 (99.2%) patients, including 91 
(67.9%) males and 42 (31.3%) females and only one 
female patient had genotype B (0.8%). Anti-HBc (total), 
anti-HBc IgM, HBeAg and anti-HBeAb were detected at 
rates of 100%, 0%, 50.4% and 46.5% respectively. The 
patient with genotype B had positive HBeAg, negative 
HBeAb and normal ALT level. This study showed that 
hepatitis B virus genotype D is the main genotype 
followed by genotype B in Duhok, Iraq.  
 
Khaled (2014), examines regular blood transfusion in 
patients with hereditary hemolytic anemia, particularly 
thalassemia, which carries a definite risk of blood-borne 
virus infection after improved overall survival. From 
March 2012 to May 2012, 480 blood samples were 
collected from thalassemia center in Ibn Al-Atheer 
hospital in Ninavha Governorate. Of these, 273 (57%) 
males and 207 (43%) females. 60 patients aged 1-5 years, 
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150 aged 6-10 years, 90 aged 16-20 years and 80 over the 
age of 20 years of age. Result shows Anti-HCV positive 
patients are 50/480 (10.4%), HCV RNA positive among 
Anti-HCV positive patients are 44/50 (88%), HBsAg 
positive is 2/480 (0.4%), and no HIV-positive cases have 
been reported. The prevalence of HCV infection is higher 
than that of HBV and HIV infection due to possibly 
infected blood transfusion among thalassemia patients. 
 
Amen (2013), determines the seroprevalence of HBV 
among patients with hemodialysis living in Mosul city, 
Iraq. This study includes (70) patients, (43) Male and 
(27) Female, age range between 10-60 years, patients 
above 50 years are more susceptible to HBV (7.1%). This 
study included age, gender, quantitative of blood pints 
transfusion, and episodes of big-time spent on 
hemodialysis. This study showed that male hemodialysis 
patients had higher HBV prevalence than females 
(14.2%, 4.2%) respectively. This study shows the 
prevalence of HBV was increased significantly with 
increasing the number of blood units transfused. Duration 
of long term dialysis less than 2 years and more than 10 
years is 4.20% of HBV positive patients, (2-4) years and 
(8-10) years in 1.40% of cases, and (4-6) years and (6-8) 
years in 2.80%, the meantime of dialysis (5.4) years. By 
ELISA technique (13) HBV positive were found among 
hemodialysis patients, but by PCR (12) were found 
positive with HBV-DNA. 
 
Mousa (2012), evaluate patients with thalassemia 
and to find out the number of patients infected with 
hepatitis B. A cross-sectional study carried out in a Tikrit 
Teaching Hospital involved (50) thalassemia patients. 
The percentage of hepatitis B among these patients was 
(10%). Among the seropositive patients, males and 
females comprised (10%) for each. Patients from urban 
and rural areas were (9.1%) and (11.8%), respectively. 
The percentage of non-vaccinated patients with 
seropositive hepatitis B was (14.3%) compared to the 
vaccinated patients (6.9%). It has been found that when 
the amount of blood transfusion increases the risk of 
hepatitis also increases. Seropositivity for hepatitis B was 
observed in (18.2%) patients with abnormal liver function 
test, and (3.6%) of the same group patients had a normal 
function test. It was revealed that (16.7%) of the 
seropositive patients had undergone splenectomy.  
 
Saadoon (2016), performed a study in the central 
blood bank in Tikrit city, from 1st July to 30th April 
2002. This study included 1300 blood donors to evaluate 
the prevalence of HBsAg and its association with age and 
blood group. This study showed that HBsAg's overall 
prevalence was 2.6% (34 out of 1300). The highest 
HBsAg frequency was found in blood group O, followed 
by B, AB and A. Most HBsAg cases accumulated in the 
30-39 year age group and 20-29 year age group 
 
Abdulrazaq and Al-Azaawie (2017), determine 
genotypes of the hepatitis B virus in chronic hepatitis B 
infection in Samara City. Blood samples of 96 patients 
include males 51 (53%), females 45 (47%) with chronic 
HBV infection were collected from Samarra General 
Hospital and blood bank in Samarra city. All the serum 
samples were tested for HBsAg, HBsAb, HBeAg, 
HBeAb, HBcIgM, and HBcIgG by ELISA and genotypes 
determined by PCR. Genotype D was the predominant 
(93.1%, 81/87) genotype in tested samples. HB genotype 
C was detected in 3.45% (3/87) of samples examined. HB 
genotype C & F, A & D, and B & D were detected in 
1.15% (1/87) for each. In cases of negative viral load, 
mean serum IL-17 value was lower (2.56 ± 1.23) as 
determined by PCR, than all other cases with D and 
mixed B and D genotypes. ANOVA tests showed no 
significance. Mean serum IL-17 was 7.94 ± 5.64 in cases 
with HB D genotype, 1.56 ± 0.57 was with genotype C, 
3.25 with B & D genotype, 2.44 with A & D genotype 
and 1.82 with C & F genotype. The difference in mean 
serum value (IL-17) was slightly significant between 
negative cases and with D genotype, but it was significant 
between D genotype and combined genotypes (P=0.0018-
0.0001). Study showed that HBV D genotype was 
predominant. 
 
Majeed (2012), determine the prevalence of the HBV 
in AL-Anbar Governorate, from January-December 2012. 
This is a retrospective study carried out at Al-Anbar 
Central Laboratory. Study group individuals age, sex and 
residency were recorded. The sera from study group 
individuals were screened by preliminary screening test, 
dipstick immunoassay based on immune-chromatography 
for HBV detection. Then all hepatitis B positive sera 
were tested for the presence of HBsAg by ELISA. 
Among blood donors, the prevalence of HBsAg was 
1.25% and among some high-risk groups includes 
contacts were 0.97%, midwife 0.64%, non-urgent 
operation was 0.63%, pregnant women were 0.46%, 
health worker was 0.28%. The highest prevalence of 
HBsAg 12.39% is recorded among routinely screened 
population and low among high-risk groups.  
 
Mahmoud (2013), assess the prevalence of HBV 
among patients attending AL-Ramadi Hospital. This 
study includes 294 serum samples. Two well-known 
serological methods for detecting HBsAg were used, i.e. 
Health mate and HBsAg ELISA kits. It has been found 
that 96 serum samples were positive (32.7%) for HBsAg 
while 198 serum samples were negative (67.4%). HBsAg 
was higher in males (40.8%) than females (26.6%) in the 
age group of 21-30 years. HBV is prevalent in the age 
group of less than 20 years (32.7%) while it is least in the 
age group > 60 years (4.4%). 
 
Al-Jumaily et al., (2013), describe the significance of 
anti-HBs alone in some high-risk groups, their 
comparison and relationship with age and other factors 
related to serological marker positivity. A cross-sectional 
study was carried out in Al-Ramadi city, Al-Anbar 
province, western Iraq, from January 2011 to July 2012. 
Anti-HBs screening was conducted on blood samples that 
were collected from five vulnerable or risk groups, 
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including hemodialysis patients, barbers, family contacts 
to a known hepatitis B patient, cuppers and health care 
workers (HCWs). Analysis was carried out using the Epi 
Info 7 software. A total of 789 subjects were screened. 
Among these, 294 are reactive to anti-HBs alone. Most of 
the groups studied showed higher rates of findings with 
high statistical significance. In concern to age, the high 
rate (45.5%) for positive testing for anti-HBs alone was 
observed at ≤ 19 years of age. Other age groups had 
lower rates ranging from (25.4-40.1%). Males showed 
higher positivity rate (38.7%) than females (33.8%). 
However, the positive history of jaundice in the past 
showed a lower rate (15.1%) than the negative history 
(40.9%), regarding anti-HBs positive alone with high 
significance (p < 0.001). The vaccinated group showed 
the highest positivity for anti-HBs alone (55.8%) and the 
difference was statistically significant (p <0.001). Also, 
unknown vaccination history status showed lower rate 
(31.1%) of high statistical significance (p < 0.001). For 
the number of vaccines versus seropositivity of anti-HBs 
alone, the highest rate (65.03%) was reported among 
those with 3 doses followed by those with 2 doses and 1 
dose (60 and 15.2%, respectively) with statistically 
significant (p-value < 0.001). In concern to the duration 
of the last dose effect on the seropositivity of anti-HBs 
alone, the last dose duration between 1 and 5 years 
showed the highest rate (57.89%), whereas those with 
duration of less than one year were slightly lower 
(56.89%). On the other hand, those with duration of more 
than 5 years were rated (39.02%) and the difference was 
statistically significant (p = 0.03).  
 
Al-Saad et al., (2009), highlight the prevalence of 
HBV and HCV among Ramadi general hospital medical 
and non-medical staff, as well as preventing further 
transmission of these viruses. This study included 422 
healthcare workers, of these 34 are female and 388 are 
male and 419 are Iraqi and only 3 are Egyptian.  
Collected sera samples were screened for HBV and HCV 
by ELISA. The prevalence of HBV among hospital 
workers was 4 out of 422 (0.94%) which was 
significantly higher than in control (0.2%), also the 
prevalence of HCV among hospital workers was 3 out of 
422 (0.71%) which was significantly higher than in 
control, no females were positive in both estimates. All 
HCV positive cases are of Egyptian nationality. A 
relatively high rate of positivity was found among 
hospital workers compared to control.  
 
Hasan (2012), determines the rate of occult HBV 
infection among unpaid blood donors in Diyala province-
Iraq. This study was conducted from May 2011 to April 
2012. A total of 186 unpaid blood donors from those 
attending the Central Blood Bank in Diyala province 
were selected by simple random selection. 171 (91.9%) 
were male and 15 (8.1%) were female. The age range was 
19 to 60 years. Sera of blood donors were subjected to 
HBsAg screening test, anti-HBs antibody, anti-HBc IgM 
antibody by ELISA, as well as detection of HBV DNA 
by conventional PCR technique. Data were statistically 
analyzed. The positivity rate of HBsAg, anti-HBc IgM 
and HBV DNA were 4.3%, 3.2% and 8.1%, respectively. 
Among the HBsAg negative blood donors, the HBc IgM 
positivity rate was 3.4% and the HBV DNA was detected 
in 3.9% (occult HBV). 
 
In another study, Hasan et al., (2018), examined the 
efficacy of HBcAbs versus HBsAg seromarkers in 
reducing the residual risk of occult hepatitis B infection 
by blood transfusion in Diyala Province. This follow-up 
study was conducted from January 2016 and August 
2017. The results of HBsAg and HBcAbs as blood units 
screening seromarkers have been followed. Simple 
statistical analysis was performed using SPSS Version 18 
and P value was considered to be significant wherever it 
is below 0.05. The total number of blood units donated 
during the follow-up period was 47258. The total HBV 
positive was 2423 (5.12%), of which 213 (0.45%) were 
HBsAg positive and 2210 (4.67%) were HBcAb (total) 
positive. Overall, 2369 (5.012%) blood donors were 
positive for both markers. All 213 HBsAg positive blood 
donors recorded throughout the two years (2016-2017) 
were male. Whereas 2145 (99.48%) and 11 (0.51%) 
blood donors are HBcAb positive were male and female 
respectively. Cumulatively, 2358 (99.53%) males and 11 
(0.46 %) females were positive for both HBV markers.  
 
Muhsin and Abdul-Husin (2013), assess the status of 
hepatitis B and C in thalassemia and haemophilic 
patients. From November (2011) to June (2012), 60 
haemophilic and 56 thalassemic patients are randomly 
selected from the Governorate of Babylon – Iraq. A total 
of (116) blood samples (71 were male and 45 were 
female) were collected with a mean age of (24.5±7.1 
years) and tested for anti-HBsAg and anti-HCV IgG 
antibody by ELISA. The anti-HBsAg reactivity was 
verified by ELFA that is carried out in the automated 
VIDAS system while the anti-HCV reactivity was 
verified by Cobas apparatus and the viral load was 
calculated using RT-PCR. No anti-HBs Ag seropositive 
cases in both haemophilia and thalassemia groups found 
in this study while the ratio of anti-HCV Ab 
seropositivity cases in hemophilia patients was (6.67%) 
among them (10.52%) were infected males while (4.5%) 
were infected females. In thalassemia, the anti-HCV 
prevalence was (25%) among them (27.27%) were males 
while (26.0%) were females. There is a higher rate of 
HCV infections in rural areas than in urban areas. More 
incidences of HCV found in people with low economic 
status, low educational level, and more in smokers than in 
nonsmokers. The results of RT-PCR and ELISA were not 
compatible with (anti-HCV IgG). 
 
Al-Marzoqi et al., (2015), describe genetic single 
nucleotide polymorphisms in human and risk factors of 
HCV among the general population and blood donors. 
Blood samples were collected from 248 patients and 70 
normal subjects as a control group. Among them, 47.2% 
are males and 52.8% are females. Blood samples from 
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248 patients were tested for HBsAg by ELISA and PCR. 
In addition, some genes were used to study the 
prevalence of hepatitis severity with human gene 
polymorphism like IFNGR, IFN-γ and IL-28B gene. The 
characteristics of the 248 patients included in the study 
are age, residence type, risk factor and gender. 
Polymorphisms in patients with HBV showed the 
existence of polymorphism in the IFNGR gene at 
chromosome 6 in position 137219896+137219995 among 
47% of patients compared with control 21%. Study of 
HBV in a healthy group against other test genes revealed 
a marked significance in the IFN-γ genes. There was a 
strong association of the IFN-γ at chr12:68158673-
68158792 with HBV compared to controls 61.4% and 
27.08% respectively. Gene expression profile with IL28B 
Genotype showed that (19.6%) patients with CC 
genotype, (71.6%) with CT (patients) and patients (8.8%) 
with TT genotype among chronic viral hepatitis B 
patients.  
 
Al-Sharifi et al., (2019), evaluate the prevalence of 
hepatitis B and C viruses in thalassemic patients and their 
association with the type of thalassemia, blood 
transfusion, and spleen status. A cross-sectional study 
was conducted on 100 multitransfused thalassemic 
patients from November 1, 2016 to January 1, 2017. 
VIDAS method is used to detect HBsAg, HBcAb IgG 
and IgM for screening of hepatitis B virus (HBV), anti-
HCV antibody and RT-PCR for hepatitis C virus (HCV) 
was done. There is no family history of HBV and HCV 
infection or history of vaccination of the patients studied. 
Twelve (12%) patients had HBcAb positive, while 3 
(3%) had HBsAg positivity, higher percentage of HCV-
infected patients (91%) received regular blood 
transfusion every 1 month., 50% of hepatitis C patients 
had splenomegaly, and 20.7% had a splenectomy.  
 
Al-Suraifi et al., (2016), detect genotypes of HBV 
among Iraqi patients with hepatitis type B using nested 
PCR protocol in Wasit Province, Iraq. This study 
included a total of 105 outpatients (65 males and 40 
females, aged 1-95 years) clinically suspected of having 
viral hepatitis. Sera of all 105 samples were positive for 
HBsAg by ELISA screen test. Whereas 72 (60.5%) and 
33 (31.4%) of these samples were positive and negative 
for HBV DNA, respectively, by first PCR. Survey of 
positive DNA samples for HBV genotypes by nested 
PCR (second PCR) showed unique results that no single 
genotype was found and all of these samples had mixed 
genotypes with pattern A+B+C+D+E were the most 
common (77.7%), followed by A+B+D+E (16.66%), 
A+B+C (2.77%), A+B+E (1.38%), and A+D+E (1.38%), 
whereas genotype F has not been found in any patient. 
Statistically, there was non-significant difference in 
genotype distribution between males and females. The 
presence of mixed infection with about 5 HBV genotypes 
in most patients results in different infection sources at 
different times and required an epidemiological 
evaluation of HBV infection. 
 
Al-Zubaidi (2019), test 88 blood samples (45 were 
male and 43 were female aged 15-82 years) for the 
detection of serological markers using ELISA and PCR 
technique for positive HBsAg. Regarding population 
group (HBsAg) positive, the seroprevalence rate of 
HBsAg, anti-HBs, anti-HBc IgM, anti-HBc Total, 
HBeAg, anti-HBe and HBV DNA were 25%, 5%, 12%, 
10%, 9%, 17% and 22% respectively. Stages of the 
disease such as chronic HBV (36.36%), acute HBV 
(25%), incubation period (17.07%), recovery stage 
(15.90%), window stage (2.27%), false positive (2.27%) 
and carrier stage (1.13%) were determined by the 
HBeAg, anti-HBe and ALT test. 
 
Kadhem et al., (2019), estimate the prevalence of 
viral hepatitis A, B and C infections and assess the 
incidence of these infections among the community 
categories, depending on gender, residence place and age 
groups. Data of 1548 positive cases of viral hepatitis A, B 
and C infections were collected from the Central Public 
Health laboratory of Misan Province from January 2013 
to December 2017. HAV was found to be the most 
predominant type, accounting for 71.4% of the cases, 
followed by HBV 18.6% and HCV 10%. Males were the 
most affected by all viral hepatitis infections by 54.47%, 
84.03% and 55.48% for HAV, HBV and HCV 
respectively. Patients residing in the city were the most 
affected by viral hepatitis infections by 75.93%, 57.64% 
and 64.52% for HAV, HBV and HCV respectively. HAV 
infections predominate in patients less than 14 years of 
age with 95.11% of viral hepatitis cases, while HBV and 
HCV most affect the age group between (25-50) years 
with 61.11% and 45.81% of viral hepatitis cases 
respectively.  
 
Hussein et al., (2019), investigate the number of 
cases of hepatitis virus infection in local and incoming 
people to the public health laboratory in DhiQar 
Governorate from January 2016 to December 2016. 
ELISA technique was used to detect HBsAg, anti-HBc 
and anti-HBs in serum specimens. Out of 4697 people, 60 
(1.27%) were seropositive to HBsAg. In December 2016 
a higher percentage (3.08%) of people with HBV 
recorded while the lowest percentage (0.20%) was 
recorded in August. HBV infections were more in male 
[39 (65%)] than in female [21 (35%)]. The percentage of 
locals infected with HBV was higher (1.6%) than that of 
incoming people (0.6%). Higher number and percentage 
[16 (26.7%)] of people infected with HBV in the 31–40 
age group and 1–10 years age group has lowest 
percentage [1 (1.7%)]. 
 
Al-Rubaye et al., (2016), investigate the prevalence 
of HBV and HCV seromarkers among blood donors in 
Basra as the basis for safe blood transfusion. A cross-
sectional study was carried out from 1 January to 31 
December 2013 at the blood banks in Basra, Iraq. Blood 
samples were collected and were tested for HBsAg, anti-
HBc and anti-HCV by ELISA and statistical analysis was 
carried out using SPSS software. A total of 69915 blood 
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donors (69658 males and 257 females) ages ranged from 
18-70 years were enrolled for the study. A total of 1625 
(2.3%) donors showed serological evidence of HBV 
infection; of those donors, 125 (0.2%) showed positive 
results for both anti-HBc and HBsAg while 1475 (2.1%) 
had positive results for anti-HBc. There was no 
significant difference between males and females 
(p=0.28). The prevalence of anti-HCV has been reported 
in 87 (0.1%) blood donors. 
 
Al-Asadi and Abdul-Jalil (2016), find out the 
seroprevalence of viral hepatitis B and C in pre-surgical 
patients admitted to Basrah General Hospital for elective 
surgery. A cross-sectional study was carried out from 
April 2014 to March 2015. Participants selected for the 
study are over 18 years of age. Demographic and medical 
information was collected. Blood samples for HBsAg and 
HCV antibodies were tested by ELISA. Out of 254 
patients (mean age 45.7±16.8 years), 63% were males, 
and 15 (5.9%) were seropositive for HBsAg, while 7 
(2.8%) were seropositive for anti-HCV. None were 
simultaneously positive for both hepatitis B and C. The 
overall seroprevalence of either hepatitis B or C was 
8.7%. Significant risk factors for viral hepatitis 
seropositivity were identified in the multivariate analysis. 
History of dental surgical intervention (OR, 12.84; 95% 
CI, 1.60-24.69; P=0.018), number of blood transfusions 
(OR, 2.39; 95% CI, 1.07-4.96; P=0.033), and tattooing 
(OR, 4.59; 95% CI, 1.09-7.33; P=0.037). 
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